Press Releases
Cytomegalovirus Infection Therapeutics Pipeline Analysis 2017

United States, 12 August 2017 -- The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline.

The prophylaxis treatment of cytomegalovirus is also increasing due to its effective and safe treatment. The U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA) are supporting the cytomegalovirus infection therapeutics pipeline by encouraging the drug development process through different types of designations. The pipeline is being driven by different factors such as increasing awareness regarding the cytomegalovirus infection treatment, high demand for safe and effective medications, technological advancements and increasing prevalence of the cytomegalovirus.

Explore Report at:

According to Centers for Disease Control and Prevention, cytomegalovirus, is a common virus that infects people of all ages. Over half of ###### by age 40 have been infected with cytomegalovirus. Once cytomegalovirus is in a person's body, it stays there for life and can reactivate., with a major number of people infected with cytomegalovirus showing no signs or symptoms of the disease. However, cytomegalovirus infection can cause serious health problems for people with weakened immune systems, as well as babies infected with the virus before they are born. When a baby is born with cytomegalovirus infection, it is called congenital cytomegalovirus infection. About one out of every 150 babies are born with congenital cytomegalovirus infection. However, only about one in five babies with congenital cytomegalovirus infection will be sick from the virus or will have long-term health problems. In some cases, infection in healthy people can cause mild illness that may include fever, sore throat, fatigue and swollen glands.

Request for Table of Content at:

Some of the companies having a pipeline of cytomegalovirus infection therapeutics include Biotest AG, Merck & Co., Inc., Chimerix Inc., Astellas Pharma, Inc., CSL Behring, Cell Medica Ltd., GlaxoSmithKline plc, Pfizer, Inc., F. Hoffmann-La Roche and AstraZeneca plc.

# # #

Submitted by Jacob, P&S Market Research on Saturday, 12 August 2017 at 5:29 AM
Category: Health Care & Medical
Related News

The best cosmetic dentistry Los Angeles
Saturday, 26 May 2018

Cell Expansion Market rising from US$7.7 bn in 2015 to US$26 bn by the end of the forecast period 20
Friday, 25 May 2018

Ductless Fume Hoods Market Size Significant Growth Opportunities to Expand During 2017 - 2025
Friday, 25 May 2018

Kana Post Delivers Innovative Tested Cannabis Products At The Cheapest Prices In Canada
Friday, 25 May 2018

Bipolar Disorder Therapeutics Market Growth to Remain Stable During the Period 2017 - 2025
Friday, 25 May 2018

Related Events

Biofilms 8 Conference
Sunday, 27 May 2018

8th International Conference on Case Reports 2018
Monday, 28 May 2018

CRISPR Agbio And NBT Congress Summit
Tuesday, 29 May 2018

Paris Healthcare Week
Tuesday, 29 May 2018

T3: Trials, Tech and Transformation
Wednesday, 30 May 2018

Latest News

Rackspace Expands to Strengthen IT as a Service Capabilities in Asia
Monday, 28 May 2018

Hurry to Buy Up to 9% off runescape gold from Rsorder for RS Classic Until June 8
Monday, 28 May 2018

Buy runescape 2007 gold with Up to $18 Vouchers for A Taste of Hope Until June 8
Monday, 28 May 2018

Aquaguard RO Customer Care
Monday, 28 May 2018

Know About the Advantages of Estate Planning
Monday, 28 May 2018

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Monday, 28 May 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Biofilms 8 Conference
  • Wolf Beach
  • 8th International Conference on Case Reports 2018
  • Belfast Summit on Global Food Integrity
  • Cyprus Gaming Show Conference, Cyprus 2018

  • Latest Jobs
    Sorry, there are currently no entries posted here.